NeuroPace (NPCE) Capital Expenditures (2020 - 2026)
NeuroPace has reported Capital Expenditures over the past 7 years, most recently at $114000.0 for Q1 2026.
- For Q1 2026, Capital Expenditures rose 208.11% year-over-year to $114000.0; the TTM value through Mar 2026 reached $90000.0, up 8900.0%, while the annual FY2025 figure was $13000.0, 31.58% down from the prior year.
- Capital Expenditures for Q1 2026 was $114000.0 at NeuroPace, up from $12000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $470000.0 in Q3 2022 and troughed at -$377000.0 in Q4 2022.
- A 5-year average of $24214.3 and a median of $15500.0 in 2024 define the central range for Capital Expenditures.
- Biggest five-year swings in Capital Expenditures: plummeted 344.81% in 2022 and later skyrocketed 325.81% in 2023.
- Year by year, Capital Expenditures stood at -$377000.0 in 2022, then skyrocketed by 80.9% to -$72000.0 in 2023, then soared by 126.39% to $19000.0 in 2024, then crashed by 36.84% to $12000.0 in 2025, then skyrocketed by 850.0% to $114000.0 in 2026.
- Business Quant data shows Capital Expenditures for NPCE at $114000.0 in Q1 2026, $12000.0 in Q4 2025, and -$24000.0 in Q3 2025.